What is Experimental Medicine and what are the key challenges?

A three-part event to engage scientists, clinicians, industry, funders and community representatives on experimental medicine to progress HIV vaccine development efforts.

Key elements of experimental medicine research are discussed against the background of ethical challenges presented by this approach to research and development, with benefits that are not immediate to study participants. It also highlights how to engage communities to achieve support.

Watch part two of the event here and part three here.

18 January 2022
English
Chair
Mark Feinberg

Mark Feinberg

IAVI

Speaker
Robin Shattock

Robin Shattock

Professor of Mucosal Infection and Immunity

Imperial College London, UK

Experimental Medicine Vaccine Trials (EMVTs) Opportunities and Challenges
Panelists
Robin Shattock

Robin Shattock

Professor of Mucosal Infection and Immunity

Imperial College London, UK

Christine Grady

Christine Grady

Chief of the Department of Bioethics

US National Institutes of Health Clinical Center

Jerome Kim

Jerome Kim

Director General

International Vaccine Institute, Korea

Carl Dieffenbach

Carl Dieffenbach

Director of the Division of AIDS (DAIDS)

National Institutes of Health, USA

Maureen Luba

Senior Programme Manager

AVAC, Malawi